Clinical trial
Homocysteine and Progression of Atherosclerosis
NCT00005338 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00005338 |
|---|---|
| Title | Homocysteine and Progression of Atherosclerosis |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cardiovascular Diseases, Peripheral Vascular Diseases, Atherosclerosis, Cerebrovascular Disorders, Myocardial Infarction, Heart Diseases, Hyperhomocysteinemia |
| Start date | Aug 1, 1991 |
| Completion | Aug 1, 2004 |
| First posted | May 26, 2000 |
| Last update posted | Feb 18, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: